vs
Side-by-side financial comparison of EnerSys (ENS) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
EnerSys is the larger business by last-quarter revenue ($919.1M vs $622.0M, roughly 1.5× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 9.8%, a 24.6% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 1.4%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 0.5%).
EnerSys is a stored energy systems and technology provider for industrial applications. The company manufactures reserve-power and motive-power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosures.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
ENS vs RPRX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $919.1M | $622.0M |
| Net Profit | $90.4M | $214.2M |
| Gross Margin | 30.1% | — |
| Operating Margin | 13.5% | 62.4% |
| Net Margin | 9.8% | 34.4% |
| Revenue YoY | 1.4% | 4.8% |
| Net Profit YoY | -21.3% | 2.9% |
| EPS (diluted) | $2.40 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $919.1M | $622.0M | ||
| Q3 25 | $951.3M | $609.3M | ||
| Q2 25 | $893.0M | $578.7M | ||
| Q1 25 | $974.8M | $568.2M | ||
| Q4 24 | $906.2M | $593.6M | ||
| Q3 24 | $883.7M | $564.7M | ||
| Q2 24 | $852.9M | $537.3M | ||
| Q1 24 | $910.7M | $568.0M |
| Q4 25 | $90.4M | $214.2M | ||
| Q3 25 | $68.4M | $288.2M | ||
| Q2 25 | $57.5M | $30.2M | ||
| Q1 25 | $96.5M | $238.3M | ||
| Q4 24 | $114.8M | $208.2M | ||
| Q3 24 | $82.3M | $544.0M | ||
| Q2 24 | $70.1M | $102.0M | ||
| Q1 24 | $60.9M | $4.8M |
| Q4 25 | 30.1% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 28.4% | — | ||
| Q1 25 | 31.2% | — | ||
| Q4 24 | 32.9% | — | ||
| Q3 24 | 28.5% | — | ||
| Q2 24 | 27.9% | — | ||
| Q1 24 | 27.9% | — |
| Q4 25 | 13.5% | 62.4% | ||
| Q3 25 | 9.7% | 70.1% | ||
| Q2 25 | 9.7% | 36.3% | ||
| Q1 25 | 13.5% | 94.0% | ||
| Q4 24 | 15.7% | 60.9% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 10.7% | 50.2% | ||
| Q1 24 | 8.9% | -13.0% |
| Q4 25 | 9.8% | 34.4% | ||
| Q3 25 | 7.2% | 47.3% | ||
| Q2 25 | 6.4% | 5.2% | ||
| Q1 25 | 9.9% | 41.9% | ||
| Q4 24 | 12.7% | 35.1% | ||
| Q3 24 | 9.3% | 96.3% | ||
| Q2 24 | 8.2% | 19.0% | ||
| Q1 24 | 6.7% | 0.8% |
| Q4 25 | $2.40 | $0.49 | ||
| Q3 25 | $1.80 | $0.67 | ||
| Q2 25 | $1.46 | $0.07 | ||
| Q1 25 | $2.39 | $0.55 | ||
| Q4 24 | $2.88 | $0.46 | ||
| Q3 24 | $2.01 | $1.21 | ||
| Q2 24 | $1.71 | $0.23 | ||
| Q1 24 | $1.48 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $450.1M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $1.9B | $9.7B |
| Total Assets | $4.0B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $450.1M | $618.7M | ||
| Q3 25 | $388.6M | $938.9M | ||
| Q2 25 | $346.7M | $631.9M | ||
| Q1 25 | $343.1M | $1.1B | ||
| Q4 24 | $463.2M | $929.0M | ||
| Q3 24 | $407.9M | $950.1M | ||
| Q2 24 | $344.1M | $1.8B | ||
| Q1 24 | $333.3M | $843.0M |
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | $1.1B | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | $802.0M | $6.1B |
| Q4 25 | $1.9B | $9.7B | ||
| Q3 25 | $1.9B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.9B | $9.8B | ||
| Q4 24 | $1.8B | $10.3B | ||
| Q3 24 | $1.8B | $10.3B | ||
| Q2 24 | $1.8B | $9.8B | ||
| Q1 24 | $1.8B | $9.9B |
| Q4 25 | $4.0B | $19.6B | ||
| Q3 25 | $4.1B | $19.3B | ||
| Q2 25 | $4.1B | $18.3B | ||
| Q1 25 | $4.0B | $17.6B | ||
| Q4 24 | $4.0B | $18.2B | ||
| Q3 24 | $4.0B | $18.0B | ||
| Q2 24 | $3.6B | $17.7B | ||
| Q1 24 | $3.5B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | 0.57× | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | 0.46× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $184.6M | $827.1M |
| Free Cash FlowOCF − Capex | $171.3M | — |
| FCF MarginFCF / Revenue | 18.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | 2.04× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $441.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $184.6M | $827.1M | ||
| Q3 25 | $218.0M | $702.6M | ||
| Q2 25 | $968.0K | $364.0M | ||
| Q1 25 | $135.2M | $596.1M | ||
| Q4 24 | $81.1M | $742.5M | ||
| Q3 24 | $33.6M | $703.6M | ||
| Q2 24 | $10.4M | $658.2M | ||
| Q1 24 | — | $664.6M |
| Q4 25 | $171.3M | — | ||
| Q3 25 | $197.1M | — | ||
| Q2 25 | $-32.1M | — | ||
| Q1 25 | $104.9M | — | ||
| Q4 24 | $56.8M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $-25.7M | — | ||
| Q1 24 | — | — |
| Q4 25 | 18.6% | — | ||
| Q3 25 | 20.7% | — | ||
| Q2 25 | -3.6% | — | ||
| Q1 25 | 10.8% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | -3.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.04× | 3.86× | ||
| Q3 25 | 3.19× | 2.44× | ||
| Q2 25 | 0.02× | 12.06× | ||
| Q1 25 | 1.40× | 2.50× | ||
| Q4 24 | 0.71× | 3.57× | ||
| Q3 24 | 0.41× | 1.29× | ||
| Q2 24 | 0.15× | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENS
| Energy Systems | $399.5M | 43% |
| Motive Power | $352.0M | 38% |
| Services | $92.6M | 10% |
| Transferred Over Time | $38.2M | 4% |
| Other | $36.8M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
